Centre for Addiction and Mental Health

Canada


Commandez votre montre hebdomadaire Centre for Addiction and Mental Health
Quantité totale PI 141
Rang # Quantité totale PI 9 425
Note d'activité PI 2,5/5.0    38
Rang # Activité PI 19 699
Classe Nice dominante Publicité; Affaires commerciales

Brevets

Marques

35 0
22 49
35 0
0
 
Dernier brevet 2025 - Treatment of cognitive and mood ...
Premier brevet 2001 - Detection of antidepressant indu...
Dernière marque 2023 - 9-8-8
Première marque 1982 - THE DONWOOD INSTITUTE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Medical tool aiding diagnosed psychosis patients in detecting auditory psychosis symptoms associa...
2024 Invention Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with...
Invention Selective ampa receptor modulators. Provided are compounds of Formula (I) and related composition...
Invention Apparatus and method for assessing active-escape bias in mammals. A series of cues are provided ...
Invention Systems and methods for facilitating digital interactions involving user arbitration between indi...
2023 P/S
Invention Eeg biomarkers for alpha5 pam dosage determination and therapeutic monitoring. AA receptor positi...
Invention Amino acid oral liquid composition. An oral liquid composition comprising an effective amount of ...
Invention Methods, compositions, and kits addressing depressed mood. A method of treating or preventing po...
2022 Invention Apparatus and method for assessing active-escape bias in mammals. A series of cues are provided t...
Invention Imidazobenzodiazepines for treatment of cognitive and mood symptoms. 4H-Benzo[f]imidazo [1,5-a][...
Invention Imidazobenzodiazepines for treatment of cognitive and mood symptoms. 4H-Benzo[f]imidazo [1,5-a][1...
Invention Biomarkers for autism spectrum disorders. Methods of determining the risk of ASD in an individual...
2021 Invention Cell based assays and kits for assessing serum cholinergic receptor activity. Provided herein ar...
2020 Invention A receptor agonists. A receptor agonists and pharmaceutical compositions and methods of treatment...
Invention Methods, compositions, and kits addressing depressed mood. Brassica oleracea vegetables, peppers,...
Invention Predictive markers of brain inflammation. Provided herein are methods for determining a level of ...
Invention Methods and compounds using in-loop fluorination. This invention provides a novel method that is ...
Invention Modulators of ampa receptor signaling. Provided are compounds of Formula (I) which have shown uti...
Invention Modulators of ampa receptor signaling. The present disclosure relates to compounds of the Formula...
Invention Mecp2e1 gene. The invention is a novel MECP2E1 splice variant and its corresponding polypeptide....
Invention Tool for assisting individuals experiencing auditory hallucinations to differentiate between hall...
Invention Compositions and methods relating to use of agonists of alpha5-containing gabaa receptors. The i...
Invention Compositions and methods relating to use of agonists of alpha5-containing gabaa receptors. The in...
2019 Invention Methods, compositions, and kits addressing depressed mood. Kits for the treatment or prophylaxis ...
Invention Methods for diagnosing or treating post-traumatic stress disorder, and compositions therefor. Pr...
Invention Methods for diagnosing or treating post-traumatic stress disorder, and compositions therefor. Pro...
2018 Invention Tool for identifying occurrence of acute incident symptomatic of mental condition or disorder. A...
Invention Methods and compositions addressing depressed mood. A method for the treatment or prophylaxis of ...
Invention Mecp2e1 gene. The invention is a novel MECP2E1 splice variant and its corresponding polypeptide. ...
Invention A cell-based assay and kits for assessing serum anticholinergic activity. Provided herein are me...
Invention A cell-based assay and kits for assessing serum anticholinergic activity. Provided herein are met...
Invention Methods, compositions and kits for assessing brain inflammation in depression and related conditi...
2016 Invention Peripheral measure of central brain inflammation, markers therefor and uses thereof. Provided are...
Invention Nucleic acids encoding polypeptides which disrupt d1-d2 dopamine receptor coupling and modulate f...
2015 Invention Genetic markers for suicide risk and related methods. The invention provides genetic markers of s...
Invention Markers for mood disorders. Disclosed is a method for diagnosing a mood disorder or susceptibilit...
Invention Methods and compositions addressing depressed mood. A method of treating or preventing depressed ...
Invention Compositions and methods for the treatment and prevention of antipsychotic medication-induced wei...
2014 Invention Genetic markers associated with suicide risk and methods of use thereof. Provided are polymorphic...
Invention Genetic markers for antipsychotic induced weight gain and methods for use thereof. Provided is a ...
2012 P/S Charitable fundraising services; Conducting fundraising events; Conducting fundraising auctions; ...
1982 P/S Educational materials, namely films, pamphlets, brochures and booklets containing advice and info...
P/S Hospital services namely the treatment of and for the abuse of drugs, alcohol, food and tobacco, ...